World's Best Scientists 2026 revealed!
Shoji Nakamori

Shoji Nakamori

D-Index & Metrics

Medicine

D-Index
78
Citations
20427
World Ranking
18106
National Ranking
580

Shoji Nakamori publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Shoji Nakamori sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 464 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Shoji Nakamori D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Shoji Nakamori sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Shoji Nakamori is affiliated with Osaka University in Japan. Their research activity is primarily situated within the field of Medicine, with significant contributions across various subfields including Surgery, Oncology, Epidemiology, Endocrinology, and Pulmonary and Respiratory Medicine. Their scholarly output spans topics such as pancreatic and hepatic oncology research, neuroendocrine tumor research advances, cholangiocarcinoma and gallbladder cancer studies, pancreatitis pathology and treatment, esophageal and gastrointestinal pathology, colorectal cancer treatments and studies, and antibiotic resistance in bacteria.

Nakamori's recent publications demonstrate engagement with clinical oncology and gastrointestinal diseases. Key papers include:

  • "nal-IRI+5-FU/LV versus 5-FU/LV in post-gemcitabine metastatic pancreatic cancer: Randomized phase 2 trial in Japanese patients" (2020, Cancer Medicine)
  • "A prolonged multispecies outbreak of IMP-6 carbapenemase-producing Enterobacterales due to horizontal transmission of the IncN plasmid" (2020, Scientific Reports)
  • "Risk factors for pancreatic fistula grade C after pancreatoduodenectomy: A large prospective, multicenter Japan-Taiwan collaboration study" (2020, Journal of Hepato-Biliary-Pancreatic Sciences)
  • "Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106" (2020, Japanese Journal of Clinical Oncology)
  • "Retrograde endoscopic submucosal dissection for early thoracic esophageal carcinoma" (2021, Clinical Journal of Gastroenterology)

Their work has been published in a variety of venues, with frequent appearances in the journal Pancreas alongside other journals such as Cancer Medicine, Scientific Reports, Journal of Hepato-Biliary-Pancreatic Sciences, and Japanese Journal of Clinical Oncology.

Nakamori collaborates often with several researchers, forming a network of frequent coauthors including:

  • Akira Fukutomi
  • Makoto Ueno
  • Takuji Okusaka
  • Junji Furuse
  • Tatsuya Ioka

Their research focus aligns heavily with pancreatic and hepatic oncology as well as neuroendocrine tumors, integrating clinical studies, surgical outcomes, and treatment evaluations. This multidisciplinary focus spans both cancer and gastrointestinal diseases, reflecting a broad scope that includes pathology and resistance mechanisms in bacteria.

Best Publications

  • Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

    Katsuhiko Uesaka;Narikazu Boku;Akira Fukutomi;Yukiyasu Okamura

  • Epithelial–mesenchymal transition in cancer development and its clinical significance

    Masaaki Iwatsuki;Koshi Mimori;Takehiko Yokobori;Hideshi Ishi

  • Increased Expression of Sialyl Lewisx Antigen Correlates with Poor Survival in Patients with Colorectal Carcinoma: Clinicopathological and Immunohistochemical Study

    Shoji Nakamori;Masao Kameyama;Shingi Imaoka;Hiroshi Furukawa

  • MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma

    Shoji Nakamori;David M. Ota;Karen R. Cleary;Keiro Shirotani

  • Genetic diagnosis of lymph-node metastasis in colorectal cancer.

    N. Hayashi;I. Ito;Y. Nakamura;A. Yanagisawa

  • Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma.

    Shinji Yamamoto;Yasuhiko Tomita;Yoshihiko Hoshida;Takaya Morooka

  • Combined intraarterial 5‐fluorouracil and subcutaneous interferon‐α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

    Masato Sakon;Hiroaki Nagano;Keizo Dono;Shoji Nakamori

  • The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase‐polymerase chain reaction

    Shinzaburo Noguchi;Tomohiko Aihara;Shoji Nakamori;Kazuyoshi Motomura

  • Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection.

    Yubo Yang;Hiroaki Nagano;Hideo Ota;Osakuni Morimoto

  • Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.

    Motoi Kondo;Hirofumi Yamamoto;Hiroaki Nagano;Jiro Okami

  • Overexpression of Cyclooxygenase-2 in Carcinoma of the Pancreas

    Jiro Okami;Hirofumi Yamamoto;Yoshiyuki Fujiwara;Masaki Tsujie

  • Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer

    Shin Nakahira;Shoji Nakamori;Masanori Tsujie;Yuji Takahashi

  • Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

    C. Morizane;T. Okusaka;J. Mizusawa;H. Katayama

  • Prevalence of Malnutrition Among Gastric Cancer Patients Undergoing Gastrectomy and Optimal Preoperative Nutritional Support for Preventing Surgical Site Infections

    Yasunari Fukuda;Kazuyoshi Yamamoto;Motohiro Hirao;Kazuhiro Nishikawa

  • Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy

    Yasunari Fukuda;Kazuyoshi Yamamoto;Motohiro Hirao;Kazuhiro Nishikawa

  • Overexpression of Small GTP-binding Protein RhoA Promotes Invasion of Tumor Cells

    Kiyoko Yoshioka;Shoji Nakamori;Kazuyuki Itoh

  • Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer.

    Kazuyoshi Yamamoto;Yukiko Nagatsuma;Yasunari Fukuda;Motohiro Hirao

  • Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.

    Terumasa Yamada;Shoji Nakamori;Hiroki Ohzato;Satoshi Oshima

  • Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.

    Yasuhiro Ito;Nariaki Matsuura;Masato Sakon;Eiji Miyoshi

  • Expression profiles of 39 HOX genes in normal human adult organs and anaplastic thyroid cancer cell lines by quantitative real-time RT-PCR system.

    Yoko Takahashi;Jun Ichi Hamada;Katsuhiko Murakawa;Minoru Takada

Frequent Co-Authors

Hiroaki Nagano
Hiroaki Nagano Osaka University
Morito Monden
Morito Monden Osaka University
Takuji Okusaka
Takuji Okusaka National Cancer Centre
Hirofumi Yamamoto
Hirofumi Yamamoto Osaka University
Osamu Ishikawa
Osamu Ishikawa Gunma University
Junji Furuse
Junji Furuse Kyorin University
Hidetoshi Eguchi
Hidetoshi Eguchi Osaka University
Takamichi Murakami
Takamichi Murakami Kobe University
Narikazu Boku
Narikazu Boku St. Marianna University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but looking for flexible online options, there are many reputable degrees and pathways to consider. Aspiring healthcare administrators can explore cahme accredited online mha programs, which offer high-quality, recognized training in a virtual format. These programs are ideal for those wanting to lead and manage in healthcare without the need for on-campus attendance.

Registered nurses aiming to advance can find online rn-bsn programs without clinicals, providing a convenient way to earn a bachelor’s degree without extra clinical requirements. For nurses ready to move into advanced practice or leadership, accelerated dnp programs help fast-track a Doctor of Nursing Practice degree.

For those concerned about the research component, there are also dnp programs without dissertation, allowing professionals to focus on practical impacts and leadership in nursing. Each option supports different career goals and offers flexible routes to advancement in the medical field.

Best Scientists Citing Shoji Nakamori

Trending Scientists

Recently Published Articles